Current Status of Epidemiology of Leishmaniases

  • Jean-Pierre Dedet
Part of the World Class Parasites book series (WCPA, volume 4)


Leishmaniases are parasitic diseases caused by protozoan flagellates of the genus Leishmania. Widely distributed around the world, they threaten 350 million people in 88 countries of four continents. The annual incidence of new cases is estimated between 1,5 and 2 million (1). In numerous countries, increasing risk factors are making leishmaniases a major public health problem (2).


Visceral Leishmaniasis Blood Meal Cutaneous Leishmaniasis Reservoir Host Intracellular Amastigote 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Desjeux, P. 1999. Global control and Leishmania/HIV co-infection. Clin Dermatol 17:317–325.PubMedCrossRefGoogle Scholar
  2. 2.
    Desjeux, P. 2001. The increase in risk factors for leishmaniosis worldwide. Trans R Soc Trop Med Hyg 95:239–243.PubMedCrossRefGoogle Scholar
  3. 3.
    Ross, R. 1903. Note on the bodies recently described by Leishman and Donovan. Brit Med J 2:1261–1262.PubMedCrossRefGoogle Scholar
  4. 4.
    Lumsden, WHR. 1974. Biochemical taxonomy of Leishmania. Trans R Soc Trop Med Hyg 68:74–75.PubMedCrossRefGoogle Scholar
  5. 5.
    Lainson, R and Shaw, JJ. Evolution, classification and geographical distribution. In: Peters W, Killick-Kendrick R, eds. 1987. The leishmaniases in Biology and Medicine. London. Academic Press 1:1–120.Google Scholar
  6. 6.
    Rioux, JA, Lanott,e G, Serres, E, et al. 1990.Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification. Ann Parasitol hum comp. 65:111–125.PubMedGoogle Scholar
  7. 7.
    Rioux, JA and Lanotte G. 1993. Apport de la cladistique l’ ľanalyse du genre Leishmania Ross, 1903 (Kinetoplastida, Trypanosomatidae). Corollaires épidémiologiques. Biosystema. 8:79 90.Google Scholar
  8. 8.
    Ward, RD. 1985. Vector biology and control. In: Chang KP, Bray RS eds. Leishmaniasis.Amsterdam: Elsevieri 99–212.Google Scholar
  9. 9.
    Lewis, DJ. 1974. The biology of Phlebotomidae in relation to leishmaniasis. Ann Rev Entomol 19:363–384.CrossRefGoogle Scholar
  10. 10.
    Killick-Kendrick, R. 1990. Phlebotomine vectors of the leishmaniases: a review. Med Vet Entomol 4: 1–24.PubMedCrossRefGoogle Scholar
  11. 11.
    Ashford, RW. 1996. Leishmaniasis reservoirs and their significance in control. Clin Dermatol 14: 523–532.PubMedCrossRefGoogle Scholar
  12. 12.
    Garnham, PCC. 1965. The Leishmanias, with special reference of the role of animal reservoirs. Am Zool 5:141–151.PubMedGoogle Scholar
  13. 13.
    Walters, LL. 1993. Leishmania differentiation in natural and unnatural sandfly hosts. J Euk Microbiol 40:196–206.PubMedCrossRefGoogle Scholar
  14. 14.
    Lainson, R and Shaw, JJ. 1979. The role of animals in the epidemiology of south American leishmaniasis. In: Lumsden WHR, Evans DA, eds. Biology of the Kinetoplastida London: Academic Press 2:1–116.Google Scholar
  15. 15.
    Barral-Netto, M, Machado, P and Barral, A. 1995. Human cutaneous leishmaniasis: recent advances in physiopathology and treatment. Europ J Dermatol 5:104–113.Google Scholar
  16. 16.
    Pratlong, F, Dedet, JP, Marty, P, et al. 1995. Leishmania-human immunodeficiency virus coinfection in the Mediterranean Basin: isoenzymatic characterization of 100 isolates of the Leishmania infantum complex. J Infec Dis 172:323–326.CrossRefGoogle Scholar
  17. 17.
    Symmers, WSC. 1960. Leishmaniasis acquired by contagion. A case of marital infection in Britain. Lancet 1:127–132.PubMedCrossRefGoogle Scholar
  18. 18.
    Alvar, J and Jimenez, M. 1994. Could infected drug-users be potential Leishmania infantum reservoirs ? AIDS 8:854.PubMedCrossRefGoogle Scholar
  19. 19.
    Dye, C and Wolpert, DM. 1988. Earthquakes, influenza and cycles of Indian kala-azar. Trans R Soc Trop Med Hyg 82:843–850.PubMedCrossRefGoogle Scholar
  20. 20.
    Thakur, CP and Kumar, K. 1992. Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes. Ann Trop Med Parasitol 86:355–359.PubMedGoogle Scholar
  21. 21.
    Seaman, J, Ashford, RW, Schorscher, J, et al.1992. Visceral leishmaniasis in southern Sudan: status of healthy villagers in epidemic conditions. Ann Trop Med Parasitol 86:481–486.PubMedGoogle Scholar
  22. 22.
    Badaro, R, Jones, TC, Carvalho, EM, et al. 1986. New perspectives on a subclinical form of visceral leishmaniasis. J infect Dis 154:1003–1011.PubMedCrossRefGoogle Scholar
  23. 23.
    Marty, P, Le Fichoux, Y, Pratlong, F, et al. 1994. Human visceral leishmaniasis in Alpes Maritimes, France: epidemiological characteristics for the period 1985-1992. Trans R Soc Trop Med Hyg 88:33–34.PubMedCrossRefGoogle Scholar
  24. 24.
    Alvar, J. 1994. Leishmaniasis and AIDS co-infection: the Spanish example. Parasitol Today 10:160–163.PubMedCrossRefGoogle Scholar
  25. 25.
    World Health Organization. Control of the leishmaniases. Report of a WHO Expert Committee. 1990. Technical Report Series 793:173.Google Scholar
  26. 26.
    Sanyal, RK, Banjerjeeb, DP, Ghosh, TK, et al. 1979. A longitudinal review of kala-azar in Bihar. J CommunDis 11:149–169.Google Scholar
  27. 27.
    Saf’janova, VM. 1971. Leishmaniasis control. Bull Wld Hlth Organ 44:561–566.Google Scholar
  28. 28.
    Davie,s CR, Llanos-Cuentas, A, Canale,s J, et al. 1994. The fall and rise of Andean cutaneous leishmaniasis: transient impact of the DDT campaign in Peru. Trans R Soc Trop Med Hyg 88:389–393.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Jean-Pierre Dedet
    • 1
  1. 1.Centre National de Référence des leishmanioses ; Laboratoire de ParasitologieCHU de MontpellierMontpellierFrance

Personalised recommendations